NEBUMET.
Nebumet is an off-the-shelf immunotherapy for the prevention and treatment of pulmonary metasteses.
NEBUMET
New targeted immunotherapy – pulmonary metastases
Immunomodulating therapy – reshapes the tumour microenvironment
Shifts towards a proinflammatory tumour microenvironment – allowing the adaptive immune system to mount an anti-tumour response
Localized effect – less systemic side effects and higher local concentration
Repurposed drug – knowledge about safety and shorter path to clinics
Short delivery time – patients are in and out of the hospital quickly
Does not require expensive machinery – can be performed in any hospital